search
Back to results

Brief COVID-19 Intervention for People With Serious Mental Illness and Co-Morbid Medical Conditions

Primary Purpose

Mental Illness, Chronic Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Integrated Illness Management and Recovery
Chronic Disease Self-Management Program
Sponsored by
Dartmouth-Hitchcock Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Mental Illness focused on measuring integrated health, mental health, illness management, cardiovascular disease, physical health

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Serious Mental Illness (diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic depression with moderate impairment in functioning) receiving services at Centerstone(KY and TN)
  • Diagnosis of a chronic medical condition increasing risk of early mortality from cardiovascular or respiratory disease (e.g., diabetes, hyperlipidemia, hypertension, COPD, heart failure, tobacco dependence, obesity), and at least 1 ER visit or hospitalization within the past year or judgment by the treatment team of substantial need for illness self-management training.

Exclusion Criteria:

  • Consumers who do not speak English
  • Consumers with either no, or a well-controlled medical condition will not be included
  • Individuals residing in a nursing home or other institution
  • Evidence of significant cognitive impairment as indicated by a Mini Mental Status Examination score <24, will be excluded

Eligibility for the COVID -related substudy is dependent on enrollment and participation in the parent project (NCT03966872).

Sites / Locations

  • Seven Counties Services
  • Centerstone

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Integrated Illness Management and Recovery (I-IMR) PLUS COVID-19 ENHANCEMENT:

Stanford Chronic Disease Self-Management Program (CDSMP) ONLY:

Arm Description

In addition to the primary intervention (Integrated Illness Management and Recovery), participants received 3 additional COVID-19 related educational/skills training sessions provided individually, remotely by I-IMR Specialists.

No additional COVID-19 intervention was provided to this group. These participants only received the primary disease management intervention (CDSMP)

Outcomes

Primary Outcome Measures

Knowledge and Behaviors for Preventing Catching and Spreading COVID-19 Scale
Change in score on this measure, which was developed as part of the study plan because no suitable scale existed to assess knowledge and safety behaviors for COVID-19. Scores range from 0-100%, with higher scores indicating greater knowledge and enactment of safety behaviors.

Secondary Outcome Measures

Full Information

First Posted
July 19, 2022
Last Updated
July 19, 2022
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Patient-Centered Outcomes Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT05467982
Brief Title
Brief COVID-19 Intervention for People With Serious Mental Illness and Co-Morbid Medical Conditions
Official Title
Brief Intervention to Increase COVID-19 Knowledge in People With Serious Mental Illness
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
April 30, 2022 (Actual)
Study Completion Date
April 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Patient-Centered Outcomes Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study will enroll 600 people with serious mental illness who receive services at Centerstone in KY or TN and will compare two different evidence-based self-management interventions: Integrated Illness Management and Recovery (I-IMR), a program developed by the study team at Dartmouth that trains people with serious mental illness on physical and mental health self-management, and the Stanford Chronic Disease Self-Management Program (CDSMP), a program largely focused on physical health self-management that has been used widely in the general population. In addition, PCORI is funding an evaluation of a COVID-related intervention that will begin in the Fall 2020.
Detailed Description
The proposed study will be the first to compare two commonly used but substantially different, evidence-based self-management interventions. Integrated Illness Management and Recovery (I-IMR), is an individually-tailored, 16-session, integrated program combining both physical and mental health self-management specifically developed for people with SMI. In contrast, the Stanford Chronic Disease Self-Management Program (CDSMP) is a group-based, 6-session, chronic disease self-management program largely focused on physical health self-management alone. I-IMR is delivered by community mental health providers or by community outreach workers, while CDSMP is co-delivered by two peers or by a health professional and a peer. Both programs have been widely recommended, disseminated, and used. The proposed parent study will randomize people with serious mental illness to I-IMR (n=300) and CDSMP (n=300). Our COVID-related Enhancement will involve enrolling 150 participants from the parent project to an evaluation of an additional I-IMR module compared to usual care during the pandemic. The I-IMR module will be delivered by trained interventionists in 3 calls over 3 weeks to n=75 I-IMR participants. The I-IMR participants and CDSMP participants will continue to receive Usual Care, consisting of generic support calls from clinicians at the study sites. Baseline, and 6, 9, and 12 week assessments will evaluate the effectiveness of the COVID-19 module that will be added to I-IMR.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mental Illness, Chronic Disease
Keywords
integrated health, mental health, illness management, cardiovascular disease, physical health

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
164 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Integrated Illness Management and Recovery (I-IMR) PLUS COVID-19 ENHANCEMENT:
Arm Type
Experimental
Arm Description
In addition to the primary intervention (Integrated Illness Management and Recovery), participants received 3 additional COVID-19 related educational/skills training sessions provided individually, remotely by I-IMR Specialists.
Arm Title
Stanford Chronic Disease Self-Management Program (CDSMP) ONLY:
Arm Type
Experimental
Arm Description
No additional COVID-19 intervention was provided to this group. These participants only received the primary disease management intervention (CDSMP)
Intervention Type
Behavioral
Intervention Name(s)
Integrated Illness Management and Recovery
Intervention Description
Education and skills training groups on illness management of chronic medical and psychiatric illness. Subsample of 75 will also receive COVID-specific Integrated Illness Management and Recovery module.
Intervention Type
Behavioral
Intervention Name(s)
Chronic Disease Self-Management Program
Intervention Description
Education and skills training groups on illness management of chronic conditions
Primary Outcome Measure Information:
Title
Knowledge and Behaviors for Preventing Catching and Spreading COVID-19 Scale
Description
Change in score on this measure, which was developed as part of the study plan because no suitable scale existed to assess knowledge and safety behaviors for COVID-19. Scores range from 0-100%, with higher scores indicating greater knowledge and enactment of safety behaviors.
Time Frame
Change from Baseline to 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Serious Mental Illness (diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic depression with moderate impairment in functioning) receiving services at Centerstone(KY and TN) Diagnosis of a chronic medical condition increasing risk of early mortality from cardiovascular or respiratory disease (e.g., diabetes, hyperlipidemia, hypertension, COPD, heart failure, tobacco dependence, obesity), and at least 1 ER visit or hospitalization within the past year or judgment by the treatment team of substantial need for illness self-management training. Exclusion Criteria: Consumers who do not speak English Consumers with either no, or a well-controlled medical condition will not be included Individuals residing in a nursing home or other institution Evidence of significant cognitive impairment as indicated by a Mini Mental Status Examination score <24, will be excluded Eligibility for the COVID -related substudy is dependent on enrollment and participation in the parent project (NCT03966872).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sarah Pratt, PhD
Organizational Affiliation
Dartmouth-Hitchcock Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seven Counties Services
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40220
Country
United States
Facility Name
Centerstone
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37228
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There are no plans to share IPD at this time.

Learn more about this trial

Brief COVID-19 Intervention for People With Serious Mental Illness and Co-Morbid Medical Conditions

We'll reach out to this number within 24 hrs